Insider Sale: Director David Fischer Sells 5,000 Shares of Balchem Corp (BCPC)

In this article:

On May 8, 2024, David Fischer, Director at Balchem Corp (NASDAQ:BCPC), executed a sale of 5,000 shares of the company. The transaction was filed on the same day through an SEC Filing.

Balchem Corp (NASDAQ:BCPC) is a company that specializes in the development, manufacture, and marketing of specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, medical sterilization, and industrial markets.

Over the past year, the insider has sold a total of 8,800 shares and has not made any purchases. The recent transaction forms part of a broader trend observed over the past year, where there have been 8 insider sells and no insider buys at Balchem Corp.

Shares of Balchem Corp were priced at $152.98 on the day of the sale, positioning the company with a market cap of approximately $5.07 billion. The price-earnings ratio of the stock stands at 44.19, which is above both the industry median of 24.47 and the company's historical median.

According to the GF Value, the intrinsic value estimate for Balchem Corp is $143.63, making the stock Fairly Valued with a price-to-GF-Value ratio of 1.07.

Insider Sale: Director David Fischer Sells 5,000 Shares of Balchem Corp (BCPC)
Insider Sale: Director David Fischer Sells 5,000 Shares of Balchem Corp (BCPC)

The GF Value is calculated based on historical multiples such as price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow, adjusted by a GuruFocus factor reflecting past returns and growth, and supplemented by future business performance estimates from Morningstar analysts.

Insider Sale: Director David Fischer Sells 5,000 Shares of Balchem Corp (BCPC)
Insider Sale: Director David Fischer Sells 5,000 Shares of Balchem Corp (BCPC)

This sale by the insider might be of interest to current and potential investors, providing insight into insider confidence and stock valuation perceptions at Balchem Corp.

This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.

This article first appeared on GuruFocus.

Advertisement